Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.02.2016 | editorial

Never too old to treat cancer?

Challenges in treating elderly and very old cancer patients

verfasst von: Univ.-Prof. Dr. Michael Pfeilstöcker, MBA

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Modern medicine has largely contributed to the remarkable increase in life expectancy in developed countries. On the other hand, this progress has also created new challenges. During the normal life span, an increasing cumulative acquisition of clonal genetic changes can be observed that predisposes to cancer and leads to the fact that cancer by itself is a predominant disease of the elderly [1]. …
Vorheriger Artikel Open Access publizieren in „memo – magazine of european medical oncology“
Nächster Artikel Treatment of elderly and very old patients with AML
Literatur
1.
Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488–98.CrossRefPubMedPubMedCentral
2.
Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–65.CrossRefPubMedPubMedCentral
3.
4.
Hamaker ME, Prins MC, Stauder R. The relevance of a geriatric assessment for elderly patients with a haematological malignancy—a systematic review. Leuk Res. 2014;38(3):275–83.CrossRefPubMed
5.
Pfeilstöcker M. Sind Methodik und Ergebnisse klinischer Studien relevant für Patienten mit Myelodysplastischen Syndromen? 2011, Masterthesis, MBA in Health Care Management, Vienna University of Economics.
6.
Metadaten
Titel
Never too old to treat cancer?
Challenges in treating elderly and very old cancer patients
verfasst von
Univ.-Prof. Dr. Michael Pfeilstöcker, MBA
Publikationsdatum
01.02.2016
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2016
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-016-0251-y

Weitere Artikel der Ausgabe 1/2016

Treatment of elderly patients with diffuse large B-cell lymphoma

  • short review

Treatment of elderly patients with advanced urological cancer

  • review

Intensive care for cancer patients

  • Open Access
  • review

Open Access publizieren in „memo – magazine of european medical oncology“

  • editorial

New approaches in graft versus host disease (GvHD) management

  • short review

Treatment of elderly patients with melanoma

  • short review